Looks like that support point is gonna get tested hard! I originally had found this stock by its unusually high options volume and bought some shares and sold contracts on them which turned out some nice 40% premiums, this was when the stock was around $5.75
Then of course the Sulonex news came out and the stock plunged. But I dont recall ever seeing such a plunge without any type of recovery as KERX has shown. I dont know what kind of appeal this stock has to any investors at this tme... One month ago this company was on the brink of possibily finding a rare and unique diabetes treatment, which clearly attracted many investors. But with that out of the way, I really dont see how this stock can rebound?
The only reason I continue to hold is so that I can reach 1.20 and hopefully break even with this. If it wasnt for the premiums I had received through the contracts, I would have been far more displeased with these events...
Bottom line, I believe this company was teetering on an announcement, if the drug succeeded, we would have soared high, if the drug failed then we lose. Obviously, the latter occured...